Ig heavy-chain gene revision: Leaping towards autoimmunity

Trends in Immunology

Volumn 22, Issue 7, 2001, Pages 400-405

  Klonowski, Kimberly D ^a   Monestier, Marc ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; RAG1 PROTEIN; RAG2 PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; AUTOIMMUNITY; B LYMPHOCYTE; BONE MARROW; CELL SPECIFICITY; GENE LOCUS; GENE REARRANGEMENT; GENE SILENCING; GENETIC RECOMBINATION; IMMUNOGLOBULIN GENE; PROTEIN EXPRESSION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; AUTOIMMUNITY; DNA-BINDING PROTEINS; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; GENES, IMMUNOGLOBULIN; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; NUCLEAR PROTEINS; RECEPTORS, ANTIGEN, B-CELL;

EID: 0034927895     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(01)01953-6     Document Type: Review

References (58)

1. B-cell commitment, development and selection
2. Altered immunoglobulin expression and functional silencing of self-reactive lymphocytes in transgenic mice
3. Clonal deletion of autospecific B lymphocytes
4. B lymphocytes may escape tolerance by revising their antigen receptors
5. Receptor editing in self-reactive bone marrow B cells
6. Receptor revision of immunoglobulin heavy chain variable region genes in normal human B lymphocytes
7. Immunoglobulin heavy chain variable region gene replacement as a mechanism for receptor revision in rheumatoid arthritis synovial tissue B lymphocytes
8. Lymphocytes rearrange, edit and revise their antigen receptors to be useful yet safe
9. V(D)J recombinase activity in a subset of germinal center B lymphocytes
10. V(D)J recombination in mature B cells: A mechanism for altering antibody responses
11. H replacement during pre-B differentiation: Non-random usage of gene segments
12. H complex formation
13. H expression in young rabbit bone marrow
14. Recombination between an expressed immunoglobulin heavy-chain gene and a germline variable gene segment in a Ly-1 B-cell lymphoma
15. H joining mechanism in heavy-chain-negative (null) pre-B cells results in heavy-chain production
16. H heptamer
17. Immunoglobulin heavy chain gene replacement: A mechanism of receptor editing
18. H replacement is unlikely to contribute significantly to receptor editing due to an ineffectual embedded recombination signal sequence
19. H gene rearrangements
20. H gene replacement in hyperselected B cells of the quasimonoclonal mouse
21. H gene replacement occurs in the spleen and bone marrow of nonautoimmune quasimonoclonal mice
22. Novel strand exchanges in V(D)J recombination
23. H region of the immunoglobulin heavy chain locus
24. The κ-deleting element. Germline and rearranged, duplicated and dispersed forms
25. Reexpression of RAG1 and RAG2 genes in activated mature mouse B cells
26. Neoteny in lymphocytes: RAG1 and RAG2 expression in germinal center B cells
27. Rearrangement of λ light chain genes in mature B cells in vitro and in vivo. Function of reexpressed recombination-activating gene (RAG) products
28. Continued RAG expression in late stages of B-cell development and no apparent re-induction after immunization
29. Immunization and infection change the number of recombination-activating gene (RAG)-expressing B cells in the periphery by altering immature lymphocyte production
30. Immunoglobulin κ-chain receptor editing in systemic lupus erythematosus
31. Enhanced mutational activity of Vκ gene rearrangements in systemic lupus erythematosus
32. Light chain contribution to specificity in anti-DNA antibodies
33. Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice
34. Novel rearrangements at the immunoglobulin D locus. Inversions and fusions add to IgH somatic diversity
35. H and junctional diversity in the fetal, adult and aged B-cell repertoires
36. Sequence of the human immunoglobulin diversity (D) segment locus: A systematic analysis provides no evidence for the use of DIR segments, inverted D segments, 'minor' D segments or D-D recombination
37. Structural patterns in anti-DNA antibodies from MRL/lpr mice
38. Autoantibodies to nucleosomes and histone-DNA complexes
39. 1 mice
40. Specificities and genetic characteristics of nucleosome-reactive antibodies from autoimmune mice
41. Relationships among anti-nuclear antibodies from autoimmune MRL mice reacting with histone H2A-H2B dimers and DNA
42. Monoclonal autoantibodies to subnucleosomes from a MRL/Mp mouse. Oligoclonality of the antibody response and recognition of a determinant composed of histones H2A, H2B and DNA
43. Residues that mediate DNA binding of autoimmune antibodies
44. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation
45. Recurrent utilization of genetic elements in V regions of anti-nucleic acid antibodies from autoimmune mice
46. HD rearrangements in human immunoglobulin heavy chain minilocus transgenic mice
47. Analysis of Ig H chain gene segment utilization in human fetal liver. Revisiting the 'proximal utilization hypothesis'
48. Preferential utilization of conserved immunoglobulin heavy chain variable gene segments during human fetal life
49. Analysis of DHQ52 gene segment transcription and rearrangement during B-cell development in human fetal bone marrow
50. H rearrangement in newborn autoimmune MRL mice
51. Variable region genes of anti-histone autoantibodies from a MRL/Mp-lpr/lpr mouse
52. Genetic diversity of murine rheumatoid factors
53. V region gene analysis of anti-Sm hybridomas from MRL/Mp-lpr/lpr mice
54. Circulating human B cells that express surrogate light chains and edited receptors
55. Heavy chain gene revision in MRL mice: A potential mechanism for the development of autoreactive B-cell precursors
56. Resolution and characterization of pro-B and pre-pro-B-cell stages in normal mouse bone marrow
57. Apoptosis in human autoimmune diseases
58. L expression by B cells in a CD49/CD29-CD106-dependent mechanism